News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
5,554 Results
Type
Article (233)
Press Release (5321)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (1675)
Career Advice (6)
Deals (258)
Drug Delivery (2)
Drug Development (646)
Employer Resources (2)
FDA (98)
Job Trends (143)
News (2813)
Policy (285)
Tag
Academia (6)
Allergies (3)
Alliances (492)
Alzheimer's disease (5)
Approvals (112)
Artificial intelligence (3)
Bankruptcy (2)
Best Places to Work (115)
Bladder cancer (2)
Brain cancer (1)
Cancer (56)
Career advice (6)
Career pathing (1)
CAR-T (3)
Cell therapy (7)
Clinical research (640)
Collaboration (16)
Compensation (24)
COVID-19 (11)
CRISPR (8)
C-suite (2)
Data (93)
Depression (2)
Diabetes (5)
Diagnostics (14)
Drug discovery (5)
Duchenne muscular dystrophy (1)
Earnings (731)
Employer resources (2)
Events (898)
Executive appointments (7)
FDA (132)
Funding (15)
Gene editing (9)
Generative AI (1)
Gene therapy (6)
GLP-1 (8)
Government (29)
Guidances (6)
Healthcare (56)
Immunology and inflammation (12)
Immuno-oncology (1)
Indications (1)
Infectious disease (12)
Inflammatory bowel disease (1)
Intellectual property (1)
IPO (106)
Job creations (30)
Job search strategy (5)
Kidney cancer (1)
Labor market (2)
Layoffs (6)
Legal (57)
Longevity (2)
Lung cancer (8)
Lymphoma (6)
Management (1)
Manufacturing (6)
MASH (1)
Medical device (12)
Medtech (12)
Mergers & acquisitions (164)
Metabolic disorders (14)
Multiple sclerosis (5)
Neurodegenerative disease (2)
Neuropsychiatric disorders (1)
Neuroscience (17)
NextGen: Class of 2026 (21)
Non-profit (10)
Now hiring (1)
Obesity (6)
Opinion (3)
Pain (4)
Pancreatic cancer (3)
Parkinson's disease (2)
Patents (6)
Patient recruitment (3)
Peanut (1)
People (506)
Phase 1 (189)
Phase 2 (264)
Phase 3 (224)
Pipeline (77)
Policy (2)
Postmarket research (20)
Preclinical (65)
Prostate cancer (5)
Psychedelics (2)
Rare diseases (9)
Real estate (49)
Recruiting (1)
Regulatory (251)
Research institute (13)
RNA editing (1)
Series A (2)
Series B (1)
Sickle cell disease (2)
Spinal muscular atrophy (2)
Startups (37)
Supply chain (4)
Tariffs (3)
The Weekly (3)
Vaccines (6)
Weight loss (2)
Worklife (1)
Date
Last 7 days (5)
Last 30 days (21)
Last 365 days (417)
2026 (33)
2025 (442)
2024 (350)
2023 (269)
2022 (391)
2021 (375)
2020 (418)
2019 (420)
2018 (287)
2017 (267)
2016 (224)
2015 (261)
2014 (180)
2013 (111)
2012 (147)
2011 (178)
2010 (183)
Location
Africa (5)
Arizona (1)
Asia (223)
Australia (51)
California (184)
Canada (38)
China (7)
Delaware (1)
Europe (972)
Florida (25)
Georgia (1)
Illinois (2)
Japan (5)
Kansas (1)
Maryland (18)
Massachusetts (190)
Minnesota (2)
New Jersey (5)
New Mexico (2)
New York (55)
North Carolina (7)
Northern California (57)
Ohio (1)
Pennsylvania (22)
Puerto Rico (1)
South America (11)
Southern California (109)
Tennessee (6)
Texas (9)
United States (530)
Virginia (1)
Washington State (4)
5,554 Results for "basilea pharmaceutica".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Basilea provides portfolio update and outlook - January 8, 2026
January 8, 2026
·
9 min read
Press Releases
Basilea and Prokaryotics enter collaboration to develop a novel broad-spectrum antifungal for the treatment of severe invasive infections
January 7, 2026
·
5 min read
Press Releases
Basilea and Phare Bio enter partnership combining anti-infectives industry expertise with unique AI capabilities for the development of a novel antibiotic
December 11, 2025
·
3 min read
Press Releases
Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea
November 4, 2025
·
3 min read
Press Releases
Basilea on track with strong 2025 half-year results
August 19, 2025
·
10 min read
Press Releases
Basilea awarded BARDA contract for the development of novel oral phase 3-ready antibiotic ceftibuten-ledaborbactam
September 25, 2025
·
5 min read
Business
Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation
Basilea Pharmaceutica Ltd announced that it has entered into an asset purchase agreement with the Glioblastoma Foundation Inc., for Basilea’s oncology drug candidate lisavanbulin, which has been developed as a potential therapy for glioblastoma, the most common type of primary brain cancer.
June 20, 2024
·
6 min read
Press Releases
Basilea receives USD 25 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
September 16, 2025
·
7 min read
Press Releases
Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic
August 14, 2025
·
7 min read
Press Releases
Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections
July 29, 2025
·
7 min read
1 of 556
Next
